4D Molecular Therapeutics CEO David Kirn disposes of 12,415 shares worth $124,987
FDMT•CEO David Kirn sells shares
- 4D Molecular Therapeutics President, CEO, director David Kirn sold 12,415 common shares on Aug. 3, 2026.
- Shares sold at a weighted average price of $10.05.
- Kirn held 871,737 shares following the transaction.
